Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 207

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 207
---
 may be attached to it, may
have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the
market value of their Ordinary Shares. The authorization and designation of a class of preferred shares will require an amendment to our
amended and restated articles of association, which requires the prior approval of the holders of a majority of the voting power attaching
to our issued and outstanding shares at a general meeting. The convening of the meeting, the shareholders entitled to participate and
the majority vote required to be obtained at such a meeting will be subject to the requirements set forth in the Companies Law as described
above in “—Voting Rights.”

Borrowing Powers

Pursuant to the Companies
Law and our amended and restated articles of association to be in effect upon completion of this offering, our board of directors may
exercise all powers and take all actions that are not required under law or under our amended and restated articles of association to
be exercised or taken by our shareholders, including the power to borrow money for company purposes.

Changes in Capital

Our amended and restated articles
of association to be in effect upon completion of this offering enable us to increase or reduce our share capital. Any such change is
subject to Israeli law and must be approved by a resolution duly passed by our shareholders at a general meeting. In addition, transactions
that have the effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings
or profits, may require the approval of both our board of directors and an Israeli court.

Transfer Agent and Registrar

The transfer agent and registrar
for our Ordinary Shares is . Its address is ,
and its telephone number is .

Listing

We have applied to have
our Ordinary Shares listed on the NYSE American under the symbol “RGNT”. No assurance can be given that our application will
be approved or that a trading market will develop.

<div align='center'>121

DESCRIPTION OF THE SECURITIES WE ARE OFFERING</div>

Ordinary Shares

The material terms and provisions
of our Ordinary Shares are described under the caption “Description of Share Capital” in this prospectus.

<div align='center'>SHARES ELIGIBLE FOR FUTURE SALE</div>

Prior to this offering, no
public market existed for our Ordinary Shares. Sales of substantial amounts of our Ordinary Shares following this offering, or the perception
that these sales could occur, could adversely affect prevailing market prices of our Ordinary Shares and